LSK Global PS is a leading Contract Research Organization (CRO) in South Korea, specializing in clinical trial-conducting. Established in 2001, the company has played a pioneering role in Korean clinical research history. LSK Global PS is dedicated to "Functional Expertise, Operational Excellence" in service, emphasizing its depth of experience and commitment to high-quality research. Operating in the biotechnology sector, the company's headquarters are located in South Korea. With a strong focus on clinical trials, LSK Global PS has gained a reputation for its expertise and operational efficiency in the industry. Although specific details on the last investment and investors are not available, the company's track record and position in a specialized market make it an intriguing prospect for venture capital. LSK Global PS's unique positioning in the Korean clinical research landscape offers potential for growth and innovation in the biotechnology sector. Together with its slogan, "A Leading Contract Research Organization (CRO), a Pioneer in Korean Clinical Research History," LSK Global PS presents itself as a compelling opportunity for investors seeking to tap into the burgeoning biotechnology market in South Korea. The company's dedication to excellence and its pivotal role in shaping Korea's clinical research history make it a noteworthy contender for strategic investment in the rapidly evolving field of biotechnology.
There is no investment information
No recent news or press coverage available for LSK Global PS.